# PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .

> **NCT03275506** · PHASE2 · COMPLETED · sponsor: **ARCAGY/ GINECO GROUP** · enrollment: 91 (actual)

## Conditions studied

- Ovarian Cancer Stage IV

## Interventions

- **DRUG:** Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
- **DRUG:** Chemotherapy - Bevacizumab

## Key facts

- **NCT ID:** NCT03275506
- **Lead sponsor:** ARCAGY/ GINECO GROUP
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-26
- **Primary completion:** 2020-09-30
- **Final completion:** 2024-03-19
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03275506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03275506, "PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer .". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03275506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*